Cyclosporine A May Be Noninferior to Mycophenolate Mofetil in the 1-Year Rejection Rate After Keratoplasty

Cornea. 2022 Feb 1;41(2):e1. doi: 10.1097/ICO.0000000000002930.

Authors

Ya-Hui Wang¹, Yi-No Kang^{2

3

4}

Affiliations

¹ Department of Ophthalmology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
² Evidence-Based Medicine Center, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
³ Cochrane Taiwan, Taipei Medical University, Taipei, Taiwan.
⁴ Institute of Health Policy and Management, College of Public Health, National Taiwan University, Taipei, Taiwan.

PMID: 34743095
DOI: 10.1097/ICO.0000000000002930

No abstract available

Publication types

Letter
Comment

MeSH terms

Corneal Transplantation*
Cyclosporine
Graft Rejection / prevention & control
Humans
Immunosuppressive Agents
Mycophenolic Acid* / therapeutic use

Substances

Immunosuppressive Agents
Cyclosporine
Mycophenolic Acid